» Articles » PMID: 35267564

Minerals and Cancer: Overview of the Possible Diagnostic Value

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Mar 10
PMID 35267564
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is the second leading cause of death worldwide and is expected to increase by one-third over the next two decades, in parallel with the growing proportion of the elderly population. Treatment and control of cancer incidence is a global issue. Since there is no clear way to prevent or cure this deadly malignancy, diagnostic, predictive, and prognostic markers for oncological diseases are of great therapeutic value. Minerals and trace elements are important micronutrients for normal physiological function of the body. They are abundant in natural food sources and are regularly included in dietary supplements whereas highly processed industrial food often contains reduced or altered amounts of them. In modern society, the daily intake, storage pools, and homeostasis of these micronutrients are dependent on certain dietary habits and can be thrown out of balance by malignancies. The current work summarizes the data on minerals and trace elements associated with abnormal accumulation or depletion states in tumor patients and discusses their value as potential tumor-associated biomarkers that could be introduced into cancer therapy.

Citing Articles

Blood trace elements in association with esophageal squamous cell carcinoma risk, aggressiveness and prognosis in a high incidence region of China.

Qiu S, Xie B, Liao J, Luo J, Liu X, He L Sci Rep. 2025; 15(1):5208.

PMID: 39939385 PMC: 11822019. DOI: 10.1038/s41598-025-89060-7.


The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors.

Liaghat M, Ferdousmakan S, Mortazavi S, Yahyazadeh S, Irani A, Banihashemi S Cell Commun Signal. 2024; 22(1):575.

PMID: 39623377 PMC: 11610171. DOI: 10.1186/s12964-024-01957-4.


Phosphorus Metabolism-Related Genes Serve as Novel Biomarkers for Predicting Prognosis in Bladder Cancer: A Bioinformatics Analysis.

He Y, Xu A, Xiao L, Yang Y, Li B, Liu Z Iran J Public Health. 2024; 53(9):1935-1950.

PMID: 39429662 PMC: 11490333. DOI: 10.18502/ijph.v53i9.16449.


Modification Role of Dietary Antioxidants in the Association of High Red Meat Intake and Lung Cancer Risk: Evidence from a Cancer Screening Trial.

Yang J, Na X, Li Z, Zhao A Antioxidants (Basel). 2024; 13(7).

PMID: 39061868 PMC: 11273743. DOI: 10.3390/antiox13070799.


Titanium dioxide nanostructure-loaded Adriamycin surmounts resistance in breast cancer therapy: ABCA/P53/C-myc crosstalk.

Abdel-Megeed R, Abdel-Hamid A, Kadry M Future Sci OA. 2024; 10(1):FSO979.

PMID: 38827789 PMC: 11140649. DOI: 10.2144/fsoa-2023-0107.


References
1.
Levental K, Yu H, Kass L, Lakins J, Egeblad M, Erler J . Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009; 139(5):891-906. PMC: 2788004. DOI: 10.1016/j.cell.2009.10.027. View

2.
Hsueh Y, Lin Y, Huang Y, Shiue H, Pu Y, Huang C . Effect of plasma selenium, red blood cell cadmium, total urinary arsenic levels, and eGFR on renal cell carcinoma. Sci Total Environ. 2020; 750:141547. DOI: 10.1016/j.scitotenv.2020.141547. View

3.
Berner Y, Shike M . Consequences of phosphate imbalance. Annu Rev Nutr. 1988; 8:121-48. DOI: 10.1146/annurev.nu.08.070188.001005. View

4.
Holle A, OBrien K, Sandler D, Janicek R, Weinberg C . Association Between Serum Iron Biomarkers and Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2020; 30(2):422-425. PMC: 7867615. DOI: 10.1158/1055-9965.EPI-20-0715. View

5.
Fan S, Li X, Zheng L, Hu D, Ren X, Ye Z . Correlations between the iodine concentrations from dual energy computed tomography and molecular markers Ki-67 and HIF-1α in rectal cancer: A preliminary study. Eur J Radiol. 2017; 96:109-114. DOI: 10.1016/j.ejrad.2017.08.026. View